Phase II Study of Bortezomib in Waldenstrom’s Macroglobulinemia: Results of WMCTG Trial 03-248.

Steven Treon; Zachary R. Hunter; Jeffrey Matous; A. Badros; Robin M. Joyce; Brian Mannion; Ranjana Advani; D. Cook; J. Songer; John Hill; Bruce R. Kaden; D. Sharon; R. Steiss; Andrew R. Branagan; Christopher J. Patterson

doi:10.1182/BLOOD.V106.11.490.490

Phase II Study of Bortezomib in Waldenstrom’s Macroglobulinemia: Results of WMCTG Trial 03-248.

Steven Treon
, Zachary R. Hunter
, Jeffrey Matous
, A. Badros
, Robin M. Joyce
, Brian Mannion
, Ranjana Advani
, D. Cook
, J. Songer
, John Hill
, Bruce R. Kaden
, D. Sharon
, R. Steiss
, Andrew R. Branagan
, Christopher J. Patterson

Harvard University
Rocky Mountain Cancer Center, Denver, CO, USA
University of Maryland, Baltimore
Beth Israel Deaconess Medical Center
St. Elizabeth’s Medical Center, Crestview Hills, KY, USA
Stanford University
Bay Regional Medical Center, Bay City, MI, USA
Ball Cancer Center, Muncie, IN, USA
Hendersonville Hematology and Oncology, Hendersonville, NC, USA
Northwest Medical Specialists, Niles, IL, USA
Monmouth Hematology and Oncology Associates, Long Branch, NJ, USA
Atlanta Cancer Care, Rosewell, GA, USA

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Blood
Volume	106
Issue number	11
DOIs	https://doi.org/10.1182/BLOOD.V106.11.490.490
State	Published - Nov 16 2005
Externally published	Yes

Disciplines

Medicine and Health Sciences
Gastroenterology
Surgery
Internal Medicine

Access to Document

10.1182/BLOOD.V106.11.490.490License: Unspecified

Cite this

@article{6c7f2910a59c44c182bf7cf998f55334,

title = "Phase II Study of Bortezomib in Waldenstrom{\textquoteright}s Macroglobulinemia: Results of WMCTG Trial 03-248.",

author = "Steven Treon and Hunter, \{Zachary R.\} and Jeffrey Matous and A. Badros and Joyce, \{Robin M.\} and Brian Mannion and Ranjana Advani and D. Cook and J. Songer and John Hill and Kaden, \{Bruce R.\} and D. Sharon and R. Steiss and Branagan, \{Andrew R.\} and Patterson, \{Christopher J.\}",

note = "Steven Treon, Zachary R. Hunter, Jeffrey Matous, A. Badros, Robin M. Joyce, Brian Mannion, Ranjana Advani, D. Cook, J. Songer, John Hill, Bruce R. Kaden, D. Sharon, R. Steiss, Andrew R. Branagan, Christopher J. Patterson; Phase II Study of Bortezomib in Waldenstrom's Macroglobulinemia: Results of WMCTG Trial 03-248.. 2005; 106 (11): 490.",

year = "2005",

month = nov,

day = "16",

doi = "10.1182/BLOOD.V106.11.490.490",

language = "American English",

volume = "106",

journal = "Blood",

publisher = "American Society of Hematology",

number = "11",

}

TY - JOUR

T1 - Phase II Study of Bortezomib in Waldenstrom’s Macroglobulinemia: Results of WMCTG Trial 03-248.

AU - Treon, Steven

AU - Hunter, Zachary R.

AU - Matous, Jeffrey

AU - Badros, A.

AU - Joyce, Robin M.

AU - Mannion, Brian

AU - Advani, Ranjana

AU - Cook, D.

AU - Songer, J.

AU - Hill, John

AU - Kaden, Bruce R.

AU - Sharon, D.

AU - Steiss, R.

AU - Branagan, Andrew R.

AU - Patterson, Christopher J.

N1 - Steven Treon, Zachary R. Hunter, Jeffrey Matous, A. Badros, Robin M. Joyce, Brian Mannion, Ranjana Advani, D. Cook, J. Songer, John Hill, Bruce R. Kaden, D. Sharon, R. Steiss, Andrew R. Branagan, Christopher J. Patterson; Phase II Study of Bortezomib in Waldenstrom's Macroglobulinemia: Results of WMCTG Trial 03-248.. 2005; 106 (11): 490.

PY - 2005/11/16

Y1 - 2005/11/16

UR - https://ashpublications.org/blood/article/106/11/490/117549/Phase-II-Study-of-Bortezomib-in-Waldenstroms

U2 - 10.1182/BLOOD.V106.11.490.490

DO - 10.1182/BLOOD.V106.11.490.490

M3 - Article

VL - 106

JO - Blood

JF - Blood

IS - 11

ER -

Phase II Study of Bortezomib in Waldenstrom’s Macroglobulinemia: Results of WMCTG Trial 03-248.

Disciplines

Access to Document

Other files and links

Cite this